Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-23-002037
Date:2023-02-27
Issuer: AKEBIA THERAPEUTICS, INC. (AKBA)
Original Submission Date:

Reporting Person:

HADAS NICOLE R.
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2023-02-27 S 6,677 d $0.81 300,564 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 this sale was made automatically by the issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on february 26, 2021.
f2 includes 1,500 shares of the issuers common stock purchased on june 30, 2022, and 1,500 shares of the issuers common stock purchased on december 30, 2022, each under the issuer's 2014 amended and restated employee stock purchase plan.
WhaleWisdom Logo

Elevate your investments